BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

689 related articles for article (PubMed ID: 23233904)

  • 1. VDAC1: from structure to cancer therapy.
    Shoshan-Barmatz V; Mizrachi D
    Front Oncol; 2012; 2():164. PubMed ID: 23233904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mitochondrial voltage-dependent anion channel 1 in tumor cells.
    Shoshan-Barmatz V; Ben-Hail D; Admoni L; Krelin Y; Tripathi SS
    Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2547-75. PubMed ID: 25448878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial VDAC1: function in cell life and death and a target for cancer therapy.
    Shoshan-Barmatz V; Golan M
    Curr Med Chem; 2012; 19(5):714-35. PubMed ID: 22204343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VDAC1 at the crossroads of cell metabolism, apoptosis and cell stress.
    Shoshan-Barmatz V; Maldonado EN; Krelin Y
    Cell Stress; 2017 Oct; 1(1):11-36. PubMed ID: 30542671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VDAC1 functions in Ca
    Shoshan-Barmatz V; Krelin Y; Shteinfer-Kuzmine A
    Cell Calcium; 2018 Jan; 69():81-100. PubMed ID: 28712506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Key regions of VDAC1 functioning in apoptosis induction and regulation by hexokinase.
    Shoshan-Barmatz V; Zakar M; Rosenthal K; Abu-Hamad S
    Biochim Biophys Acta; 2009 May; 1787(5):421-30. PubMed ID: 19094960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VDAC1-based peptides: novel pro-apoptotic agents and potential therapeutics for B-cell chronic lymphocytic leukemia.
    Prezma T; Shteinfer A; Admoni L; Raviv Z; Sela I; Levi I; Shoshan-Barmatz V
    Cell Death Dis; 2013 Sep; 4(9):e809. PubMed ID: 24052077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Voltage-Dependent Anion Channel 1 As an Emerging Drug Target for Novel Anti-Cancer Therapeutics.
    Shoshan-Barmatz V; Krelin Y; Shteinfer-Kuzmine A; Arif T
    Front Oncol; 2017; 7():154. PubMed ID: 28824871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uncovering the role of VDAC in the regulation of cell life and death.
    Shoshan-Barmatz V; Keinan N; Zaid H
    J Bioenerg Biomembr; 2008 Jun; 40(3):183-91. PubMed ID: 18651212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptosis is regulated by the VDAC1 N-terminal region and by VDAC oligomerization: release of cytochrome c, AIF and Smac/Diablo.
    Shoshan-Barmatz V; Keinan N; Abu-Hamad S; Tyomkin D; Aram L
    Biochim Biophys Acta; 2010; 1797(6-7):1281-91. PubMed ID: 20214874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective induction of cancer cell death by VDAC1-based peptides and their potential use in cancer therapy.
    Shteinfer-Kuzmine A; Amsalem Z; Arif T; Zooravlov A; Shoshan-Barmatz V
    Mol Oncol; 2018 Jun; 12(7):1077-1103. PubMed ID: 29698587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Voltage-dependent anion channel 1-based peptides interact with hexokinase to prevent its anti-apoptotic activity.
    Arzoine L; Zilberberg N; Ben-Romano R; Shoshan-Barmatz V
    J Biol Chem; 2009 Feb; 284(6):3946-55. PubMed ID: 19049977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The BH4 domain of anti-apoptotic Bcl-XL, but not that of the related Bcl-2, limits the voltage-dependent anion channel 1 (VDAC1)-mediated transfer of pro-apoptotic Ca2+ signals to mitochondria.
    Monaco G; Decrock E; Arbel N; van Vliet AR; La Rovere RM; De Smedt H; Parys JB; Agostinis P; Leybaert L; Shoshan-Barmatz V; Bultynck G
    J Biol Chem; 2015 Apr; 290(14):9150-61. PubMed ID: 25681439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VDAC1 as a Player in Mitochondria-Mediated Apoptosis and Target for Modulating Apoptosis.
    Shoshan-Barmatz V; Krelin Y; Chen Q
    Curr Med Chem; 2017; 24(40):4435-4446. PubMed ID: 28618997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hexokinase-I protection against apoptotic cell death is mediated via interaction with the voltage-dependent anion channel-1: mapping the site of binding.
    Abu-Hamad S; Zaid H; Israelson A; Nahon E; Shoshan-Barmatz V
    J Biol Chem; 2008 May; 283(19):13482-90. PubMed ID: 18308720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular model of hexokinase binding to the outer mitochondrial membrane porin (VDAC1): Implication for the design of new cancer therapies.
    Rosano C
    Mitochondrion; 2011 May; 11(3):513-9. PubMed ID: 21315184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VDAC, a multi-functional mitochondrial protein regulating cell life and death.
    Shoshan-Barmatz V; De Pinto V; Zweckstetter M; Raviv Z; Keinan N; Arbel N
    Mol Aspects Med; 2010 Jun; 31(3):227-85. PubMed ID: 20346371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oligomerization of the mitochondrial protein VDAC1: from structure to function and cancer therapy.
    Shoshan-Barmatz V; Mizrachi D; Keinan N
    Prog Mol Biol Transl Sci; 2013; 117():303-34. PubMed ID: 23663973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mediation of the antiapoptotic activity of Bcl-xL protein upon interaction with VDAC1 protein.
    Arbel N; Ben-Hail D; Shoshan-Barmatz V
    J Biol Chem; 2012 Jun; 287(27):23152-61. PubMed ID: 22589539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VDAC, a multi-functional mitochondrial protein as a pharmacological target.
    Shoshan-Barmatz V; Ben-Hail D
    Mitochondrion; 2012 Jan; 12(1):24-34. PubMed ID: 21530686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.